Appetite suppressant semaglutide is to be made available to treat obesity in England. Iacobucci G. BMJ 2023;380:p556.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Iacobucci G. Appetite suppressant semaglutide is to be made available to treat obesity in England. BMJ 2023;380:p556.
PMID: 36889753